| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.6 | 0.0001 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |